Articles from P3 Health Partners Inc.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on Tuesday, December 3, 2024, in Boca Raton, FL, at 3:30 pm Eastern Time.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced the Company will participate in the following upcoming investor conferences:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2024.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2024 and file its Quarterly Report on Form 10-Q on Tuesday, November 12, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the LD Micro Main Event XVII Conference on Wednesday, October 30, 2024, in Los Angeles, CA, at 2:30 pm Eastern Time.

P3 Health Partners Inc. ("P3") (NASDAQPIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company will participate at the following upcoming investor conferences:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2024.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, August 7, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, will participate at the following upcoming investor conferences:

P3 Health Partners Inc. (Nasdaq: PIII), a patient- centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with certain institutional investors. The lead institutional investors in the private placement are affiliates of Chicago Pacific Founders (“CPF”). The transaction is expected to result in gross proceeds of approximately $42.2 million, including approximately $20.0 million of gross proceeds from purchases by affiliates of CPF, before deducting placement agent fees and offering expenses.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), today reported that the Board of Directors (the “Board”) (including the independent members of the Board) approved the award of employment inducement equity grants to Aric Coffman, M.D. in connection with his agreement to serve as the Company’s Chief Executive Officer and President as follows: effective as of May 9, 2024, the grant of an employment inducement stock option award covering 12,100,000 Class A shares of P3’s common stock, par value $0.0001 (the “Common Stock”), and an employment inducement restricted stock unit (RSU) award covering 4,400,000 shares of Common Stock. The stock option will vest and become exercisable over a four-year period with respect to 25% of the shares subject to the option on the first anniversary of the effective date of Dr. Coffman’s employment, and with respect to the remaining 75% of the shares subject to the option in substantially equal installments on each three-month anniversary over the three (3)-year period thereafter, subject to Dr. Coffman’s continued employment with P3 through the applicable vesting date. The RSU award will be subject to both service-vesting and performance-vesting conditions, such that both conditions must be met for the RSU award to vest, subject to Dr. Coffman’s continued employment with P3 through the applicable vesting date. The service-vesting condition will follow the same vesting schedule as the stock option. The performance-vesting condition will be satisfied upon the closing of P3’s first underwritten offering and sale of its Common Stock. The awards were granted under P3’s 2024 Employment Inducement Incentive Award Plan as employment inducement awards in accordance with Nasdaq Listing Rule 5635(c)(4).

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), today named Dr. Aric Coffman as P3’s Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3’s Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company’s Board of Directors working closely with Dr. Coffman to ensure a smooth transition.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2024.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, May 8, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 1:30 pm Eastern Time.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and affirmed its 2024 guidance.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for the fourth quarter and full year 2023 on March 28, 2024 and is reaffirming its 2024 guidance.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that leadership is scheduled to present at the KeyBanc LifeSciences & Medtech Investor Forum virtually on Tuesday, March 19, 2024 at 3:45pm ET.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced management will participate in the upcoming Jefferies Value Based Healthcare Summit in Miami Beach, Florida.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the TD Cowen 44th Annual Health Care Conference in Boston on Monday, March 4, 2024 at 10:30 am Eastern Time.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that leadership will participate in the BTIG Digital Health Forum, being held virtually, on Monday, November 20, 2023, including a panel discussion with Dr. Sherif Abdou, Chief Executive Officer and Co-founder of P3, at 12:00 p.m. PT/3:00 p.m. ET.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2023.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on Wednesday, November 8, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that it will participate in the Lake Street Best Ideas Growth Conference in New York, New York on Thursday, September 14th, 2023.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that it will participate at the upcoming Wells Fargo Healthcare Conference in Boston, Massachusetts.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2023.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for second-quarter 2023 and file its quarterly report on Form 10-Q on Monday, August 7, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces William “Bill” Bettermann as its Executive Vice President and Chief Operating Officer.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2023.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for first-quarter 2023 and file its quarterly report on Form 10-Q on Wednesday, May 10, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2022.

P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with a group of institutional investors. The lead institutional investors in the private placement are affiliates of Chicago Pacific Founders (“CPF”) and Leavitt Partners. The transaction is expected to result in gross proceeds of approximately $90 million, before deducting placement agent fees and offering expenses, including $71 million of gross proceeds from purchases by affiliates of CPF.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announced that it will now release results for fourth-quarter 2022 and full-year ended December 31, 2022 on Friday, March 31, 2023 before the market open. In connection with this release, management will host a conference call and webcast on Friday, March 31, 2023 at 8:30 AM Eastern Time to provide a corporate and financial update. The call details are below:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that the Company expects to release its financial results for fourth-quarter 2022 and full-year ended December 31, 2022 and file its Annual Report on Form 10-K on Thursday, March 30, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that it expects to file the Company’s Annual Report on Form 10-K on or before the close of business on March 30th, 2023 and that it plans to host an Earnings Call to review those results following the market close on the same day.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that Dr. Amir Bacchus, co-founder and Chief Medical Officer, will be participating in a fireside chat at the upcoming Jefferies Value-Based Care Summit in Miami Beach, FL on March 13, 2023. Dr. Bacchus will be participating at 2:45PM Eastern Time.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces that Dr. Sherif Abdou, P3’s co-founder and Chief Executive Officer, is scheduled to present at the TD Cowen 43rd Annual Health Care Conference in Boston on Tuesday, March 7, 2023 at 1:30 pm Eastern Time. A live audio webcast of the presentation is available here. A replay will be available on P3’s investor relations webpage for 30 days following the presentation.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, is participating in J.P. Morgan’s 41st Annual Healthcare Conference, being held in San Francisco, CA from January 9-12, 2023. In advance of the associated presentation, P3 is reaffirming full-year 2022 financial guidance and announcing financial guidance for the full-year 2023.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, is participating in J.P. Morgan’s 41st Annual Healthcare Conference, to be held in San Francisco, CA from January 9-12, 2023.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced Atul Kavthekar will be joining the Company as Chief Financial Officer (CFO), on December 12, 2022.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that the Company expects to release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. In connection with this announcement, management will host a conference call and provide a corporate and financial update. Details for the conference call are as follows.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, is scheduled to participate in a “fireside chat” at the Credit Suisse 31st Annual Healthcare Conference, on Wednesday, Nov. 9, at 2:35 p.m. PST in Rancho Palos Verdes, Calif.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, announces receipt of an October 24, 2022 letter (the “Compliance Letter”) from the Nasdaq Hearing Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company’s filing delinquency has been cured and that the Company is now in compliance with all applicable listing standards. As a result, the hearing before the Panel, previously scheduled for November 3, 2022, had been determined to be moot and was canceled, and the Company’s securities will continue to be listed and traded on Nasdaq.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that on September 28, 2022 it received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq has initiated a process which could result in the delisting of the Company’s securities from Nasdaq as a result of the Company not being in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Staff Determination has no immediate effect and will not immediately result in the suspension of trading or delisting of the Company’s securities.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its Chief Executive Officer, Dr. Sherif Abdou, will participate on the “Next Frontier – Value Based Care for Sub-Capitation/Specialties” virtual panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22nd at 9:00 am EDT.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners, LLC dba P3 Health Partners-Arizona (“P3 Arizona”) has acquired the practice of Dr. Leonardo Serfino, M.D., in Sierra Vista, Ariz.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) has named Allen Pate as president.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) is expanding its footprint in Nye County with the recent acquisition of a cardiology and multi-specialty practice.

P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) and Humana, a leading health and well-being company, have signed an agreement that gives Humana Medicare Advantage members access to P3’s primary care provider (“PCP”) network.